参考文献:1.WHO CVD Strategy: cardiovascular diseases—prevention and control 2001–2002. Geneva: WHO; 2002. 2.Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.PubMed CrossRef 3.Global burden disease estimates (http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/ ). 4.Fang J, Alderman MH. Trend of stroke hospitalization, United States, 1988-1997. Stroke. 2001;32(10):2221–6.PubMed CrossRef 5.O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–23.PubMed CrossRef 6.Buttar HS, Li T, Ravi N. Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 2005;10(4):229–49.PubMed PubMedCentral 7.Owolabi MO, Agunloye AM. Risk factors for stroke among patients with hypertension: a case-control study. J Neurol Sci. 2012;325(1–2):51–6.PubMed 8.Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(7):2064–89.PubMed CrossRef 9.Grond M, von Kummer R, Sobesky J, Schmulling S, Rudolf J, Terstegge K, Heiss W. Early x-ray hypoattenuation of brain parenchyma indicates extended critical hypoperfusion in acute stroke. Stroke. 2000;31(1):133–9.PubMed CrossRef 10.Cohen W, Wayman L. Computed tomography of intracranial hemorrhage. Neuroimaging Clin N Am. 1992;2:75–87. 11.Roth GA, Fihn SD, Mokdad AH, Aekplakorn W, Hasegawa T, Lim SS. High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries. Bull World Health Organ. 2011;89(2):92–101.PubMed PubMedCentral CrossRef 12.Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG, editors. AUDIT: the alcohol use disorders identification test guidelines for use in primary care. Geneva: WHO; 2001. 13.Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.CrossRef 14.Gurpreet K, Tee GH, Karuthan C. Evaluation of the accuracy of the Omron HEM-907 blood pressure device. Med J Malaysia. 2008;63(3):239–43.PubMed 15.Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, et al. American heart association prevention conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke. 1997;28(7):1507–17.PubMed CrossRef 16.Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005;36(9):1859–63.PubMed CrossRef 17.Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR. Prehypertension and cardiovascular disease risk in the women’s health initiative. Circulation. 2007;115(7):855–60.PubMed CrossRef 18.Tsika EP, Poulimenos LE, Boudoulas KD, Manolis AJ. The J-curve in arterial hypertension: fact or fallacy? Cardiology. 2014;129(2):126–35.PubMed CrossRef 19.Owolabi MO, Ugoya S, Platz T. Racial disparity in stroke risk factors: the Berlin-Ibadan experience; a retrospective study. Acta Neurol Scand. 2009;119(2):81–7.PubMed CrossRef 20.O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–23.PubMed CrossRef 21.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.PubMed CrossRef 22.Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. dash-sodium collaborative research group. N Engl J Med. 2001;344(1):3–10.PubMed CrossRef 23.Muntner P, Halanych JH, Reynolds K, Durant R, Vupputuri S, Sung VW, Meschia JF, Howard VJ, Safford MM, Krousel-Wood M. Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study. J Clin Hypertens (Greenwich). 2011;13(7):479–86.CrossRef 24.Bailey JE, Wan JY, Tang J, Ghani MA, Cushman WC. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med. 2010;25(6):495–503.PubMed PubMedCentral CrossRef 25.Ovbiagele B, Campbell S, Faiz A, Chambless LE. Relationship between non-specific prescription pill adherence and ischemic stroke outcomes. Cerebrovasc Dis. 2010;29(2):146–53.PubMed PubMedCentral CrossRef 26.Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2007;167(16):1798–803.PubMed PubMedCentral CrossRef 27.Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008;117(22):2884–92.PubMed CrossRef 28.Bahar Z, Kizilci S, Beser A, Besen DB, Gordes N, Ersin F, Kissal A, Capik C. Herbal therapies used by hypertensive patients in Turkey. Afr J Tradit Complement Altern Med. 2012;10(2):292–8.PubMed PubMedCentral 29.Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009;93(3):753–69.PubMed PubMedCentral CrossRef 30.Vawter L, Tong X, Gemilyan M, Yoon PW. Barriers to antihypertensive medication adherence among adults—United States, 2005. J Clin Hypertens (Greenwich). 2008;10(12):922–9.CrossRef 31.O’Carroll RE, Chambers JA, Dennis M, Sudlow C, Johnston M. Improving adherence to medication in stroke survivors: a pilot randomised controlled trial. Ann Behav Med. 2013;46(3):358–68.PubMed CrossRef 32.Chambers JA, O’Carroll RE, Hamilton B, Whittaker J, Johnston M, Sudlow C, Dennis M. Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol. 2011;16(3):592–609.PubMed CrossRef 33.Cummings DM, Letter AJ, Howard G, Howard VJ, Safford MM, Prince V, Muntner P. Medication adherence and stroke/TIA risk in treated hypertensives: results from the REGARDS study. J Am Soc Hypertens. 2013;7(5):363–9.PubMed CrossRef 34.Rose AJ, Berlowitz DR, Manze M, Orner MB, Kressin NR. Intensifying therapy for hypertension despite suboptimal adherence. Hypertension. 2009;54(3):524–9.PubMed PubMedCentral CrossRef 35.Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37(9):846–57.PubMed CrossRef 36.Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.PubMed PubMedCentral 37.Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke. 1989; 20(10):1407–31.
作者单位:Isaac Mugwano (1) Mark Kaddumukasa (2) Levi Mugenyi (3) (5) James Kayima (2) Edward Ddumba (1) Martha Sajatovic (4) Cathy Sila (4) Michael DeGeorgia (4) Elly Katabira (2)
1. Mother Kevin Post Graduate Medical School, Nsambya Hospital, Uganda Martyr’s University, P. O. Box 5498, Kampala, Uganda 2. Department of Medicine, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda 3. Infectious Diseases Research Collaboration, Mulago Hill Road, MUJHU3 Building, P. O. Box 7475, Kampala, Uganda 5. I-Biostat, University of Hasselt, 3590, Diepenbeek, Belgium 4. Neurological and Behavioral Outcomes Center, University Hospital Case Medical Center, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA
刊物主题:Biomedicine general; Medicine/Public Health, general; Life Sciences, general;
出版者:BioMed Central
ISSN:1756-0500
文摘
Background Raised blood pressure (BP) remains an important risk factor for cardiovascular diseases such as stroke. Adherence to therapeutic recommendations especially antihypertensive drugs is important in BP control. The aim of the study was to assess the stroke risk factors and levels of adherence among hypertensive patients with stroke in Kampala Uganda.